| 08-Oct-2021 | S | Board approves split of shares of the Company
Earum Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
(As Per BSE Announcement Dated 11.11.2021)
Trading Members of the Exchange are hereby informed that EARUM PHARMACEUTICALS LTD. has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
EARUM PHARMACEUTICALS LTD.
(542724)
RECORD DATE
18/12/2021
PURPOSE
Sub Division of existing equity shares from every One equity share of Rs. 10/- each into Five equity shares of Rs. 2/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
16/12/2021 DR-178/2021-2022
Note:-
i. ISIN No. INE060601015 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 16/12/2021.
ii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 30.11.2021)
In Continuation of Notice No. 20211130-57 dated November 30, 2021, Trading Members of the Exchange are hereby informed that the New ISIN number for the equity shares of the company will be as under: -
Company Name & Scrip Code
EARUM PHARMACEUTICALS LTD.
(542724)
New ISIN No.
INE060601023
Remarks
Sub-division of equity shares from Rs.10/- to Rs.2/-
The new ISIN number given above, for Equity Shares of Rs.2/- each of the company shall be effective for trades done on and from the Ex-Date i.e. 16-12-2021 (DR-178/2021-2022)
(As Per BSE Notice Dated on 09.12.2021) | 18-Dec-2021 | |
| 30-Jul-2021 | B | 1:1 Bonus Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, Earum Pharmaceuticals Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Earum Pharmaceuticals Limited
(542724)
RECORD DATE
10/08/2021
PURPOSE
Issue of 1 (One) Bonus equity shares of Rs.10/- each for every 1 (One) existing equity share of Rs.10/- each held.
Ex-Bonus basis from Date & Sett. No.
09/08/2021 DR-090/2021-2022
Trading Members are requested to note the change in the market lot of Earum Pharmaceuticals Limited (542724) pursuant to the Bonus Issue of equity shares as given below, which will be effective from Tuesday, August 10, 2021:
Scrip Code
542724
Scrip Name
Earum Pharmaceuticals Limited
Current Market Lot
1500
Revised Market Lot
3000
(As Per BSE Notice Dated on 30.07.2021) | 10-Aug-2021 | 1:1 |
| 31-Mar-2023 | R | 4:1 Right Issue of Equity Shares
Trading Members of the Exchange are hereby informed that Earum Pharmaceuticals Limited has fixed Record Date for the purpose of Rights Issue of Equity Shares. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Earum Pharmaceuticals Limited
(542724)
RECORD DATE
10.04.2023
PURPOSE
Issue of 04 (Four) Equity Shares of Rs.2/- each for cash at Par on Rights Basis for every 01 (One) Equity Share of Rs.2/- held.
Ex-Right basis from Date & Sett. No.
10/04/2023 DR-505/2023-2024
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 03.04.2023) | 10-Apr-2023 | 4:1 |
| 09-Nov-2024 | BC | Murae Organisor Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listi | 14-Nov-2024 | |
| 09-Nov-2024 | BC | Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company held today i.e., S | 09-Nov-2024 | |
| 09-Nov-2024 | BC | Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company held today i.e., S | 09-Nov-2024 | |
| 22-Oct-2024 | BC | Trading members of the Exchange are hereby informed that the under mentioned new securities of Murae Organisor Limited (Scrip Code - 542724) are listed and permitted to trade on the Exchange with eff | 23-Oct-2024 | |
| 10-Oct-2024 | BC | Murae Organisor Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listi | 15-Oct-2024 | |
No Dividends has been declared by Earum_Pharmaceu.
Record Date10-Aug-2021
Ex-Bonus Date09-Aug-2021
Ratio1:1
Record Date18-Dec-2021
Split Date16-Dec-2021
Face Value (Before/After)10/2
RightsRecord Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)0
Ratio4:1
Book Closure
| 14-Nov-2024 | - | Murae Organisor Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listi |
| 09-Nov-2024 | - | Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company held today i.e., S |
| 09-Nov-2024 | - | Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company held today i.e., S |
| 23-Oct-2024 | - | Trading members of the Exchange are hereby informed that the under mentioned new securities of Murae Organisor Limited (Scrip Code - 542724) are listed and permitted to trade on the Exchange with eff |
| 15-Oct-2024 | - | Murae Organisor Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listi |